News
Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to ...
Women aged 40 years and older have a 50% greater risk for chronic obstructive pulmonary disease (COPD) vs men in the same age group, according to study findings published in BMJ Open Respiratory ...
COPD has a large economic impact on the healthcare system and a destructive impact on the lives of patients and their ...
Prevalence of chronic obstructive pulmonary disease (COPD) and the disease's burden varies significantly by state.
Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death ...
Investigators concluded that individuals with comorbidities experienced higher risks of severe COVID-19 outcomes during the ...
Researchers looked at lung tissue from 28 COPD patients and 15 smokers who underwent surgery for suspected or confirmed lung ...
Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.
Pulmonary Drug Delivery System Market Size to Worth USD 73.14 Billion by 2031 | The Insight Partners
According to a new comprehensive report from The Insight Partners, the global pulmonary drug delivery system market is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results